PDCD1 and metastatic malignant neoplasm in the lymph nodes: The results indicated that large tumor diameter, poor tumor differentiation, deep tumor invasion, lymph node metastasis, and high expression of PD-1, PD-L1, FOXP3, and CD25 were independent risk factors for EC prognosis (P < 0.05) (Table 1).